Gout management and outcomes during the COVID-19 pandemic: a cross-sectional internet survey

Jasvinder A Singh1, N Lawrence Edwards2

  • 1University of Alabama at Birmingham, Faculty Office Tower 805B, 510 20th Street South, Birmingham, AL 35294, USA.

Insights

Gout patients faced challenges in medication adherence and healthcare access during the COVID-19 pandemic, leading to increased flares and distress. Targeted interventions are crucial to improve gout management and quality of life for these individuals.

Area of Science:

  • Rheumatology
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic significantly disrupted healthcare delivery and patient management for chronic conditions.
  • Gout, a common inflammatory arthritis, requires consistent management to prevent flares and long-term complications.

Purpose of the Study:

  • To evaluate gout management, including medication use, healthcare access, quality of life, and psychological distress among gout patients during the COVID-19 pandemic.
  • To identify challenges faced by individuals with gout during the pandemic and inform necessary interventions.

Main Methods:

  • A cross-sectional online survey was conducted among 122 individuals with physician-diagnosed gout.
  • Data collected included medication use (urate-lowering therapy - ULT), healthcare utilization, Gout Impact Scale (GIS) for quality of life, Patient Health Questionnaire-4 (PHQ-4) for psychological distress, and resilience.

Main Results:

  • 82% of participants were prescribed ULT, with 66% taking it daily. Gout flares were frequent (63% monthly), with some requiring emergency care (11%) or hospitalization (2%).
  • Significant difficulties were reported in gout management (41-56%) and healthcare access (17-37%). HRQoL deficits were noted, particularly for unmet treatment needs and gout concern during flares.
  • Moderate to severe psychological distress (34%) was associated with increased challenges in medication access, flare management, and receiving gout education.

Conclusions:

  • People with gout experienced significant healthcare gaps, psychological distress, and reduced quality of life during the COVID-19 pandemic.
  • There is a clear need for interventions to address these challenges and improve the comprehensive management of gout during public health crises.
Abstract

Related Concept Videos

Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
890
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
150
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
101
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
111
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
146
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
170